TruBridge, Inc. Hits New 52-Week High of $26.23, Up 168.75%

TruBridge, Inc., a microcap company in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 26.23 on July 1, 2026. This achievement underscores the company's strong performance over the past year, with a remarkable increase of 168.75%, significantly outpacing the S&P 500's growth of 20.74% during the same period. The company's financial metrics reflect a solid position within its industry. TruBridge boasts a price-to-earnings (P/E) ratio of 19.00 and a price-to-book ratio of 1.18, indicating a fair valuation. With a return on equity (ROE) of 6.15%, the company has demonstrated consistent profitability, supported by a robust operating cash flow of USD 46.66 million and a net profit of USD 10.95 million in the most recent half-year period. TruBridge's debt-to-equity ratio stands at 0.81, suggesting a manageable level of debt. Additionally, the company has seen a 4.62% increase in institutional holdings, which currently sit at 72.34%, reflecting confidence from larger investors in its financial health and operational performance.